QUCYNasdaqPharmaceutical PreparationsFiscal year ends December 31

Quantum Cyber N.V.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026

$1.07+0.01 (+0.94%)

Close on Oct 19, 2026

Market cap: $19.10M
P/E (TTM): –
Dividend yield: –

Quantum Cyber N.V. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31
Revenue	0.54	0.89	0.90	0.53	0.58	0.49	0.28
Cost of Revenue	0.15	0.32	0.39	0.35	0.40	0.37	0.34
Gross Profit	0.39	0.57	0.51	0.18	0.18	0.12	-0.06
Research & Development	4.91	5.72	9.59	5.02	0.48	0.31	0.25
Selling, General & Admin	8.93	13	11	15	8.46	0.37	–
Selling & Marketing	3.82	6.58	6.16	6.40	0.96	0.11	0.18
General & Administrative	5.11	6.65	–	–	–	–	–
Advertising Expenses	–	4.57	3.70	4.93	–	–	–
Operating Expenses	17	19	27	27	9.90	0.80	0.86
Operating Income	-16	-19	-27	-26	-9.72	-0.67	-0.92
Interest Expense	0.37	0.95	0.52	0.24	0.34	0.18	0.16
Other Non-Operating Income	-0.07	-2.83	–	–	–	–	–
Merger & Restructuring Charges	–	0.28	–	–	–	–	–
Asset Impairment Charges	2.64	0.05	–	–	–	–	–
Gain (Loss) on Sale of Assets	-0.16	0.05	–	–	–	–	–
Pretax Income	-16	-22	-26	-26	-12	-0.59	-0.96
Income from Continuing Operations	–	22	26	26	12	0.59	-0.96
Net Income incl. Noncontrolling Interests	–	-22	-26	-26	-12	-0.59	-0.96
Net Income	-16	-22	-26	-26	-12	-0.59	–
EPS (Basic)(per share)	-2.70	-21.91	-64.76	-74.55	-64.80	-4.00	-6.80
EPS (Diluted)(per share)	-2.70	-21.91	-64.76	-74.55	-64.80	-4.00	–
Shares Outstanding (Basic, Weighted)(shares)	6.00	0.99	0.41	0.35	0.18	0.14	0.14
Shares Outstanding (Diluted, Weighted)(shares)	6.00	0.99	0.41	0.35	0.18	0.14	0.14
EBITDA	-16	-18	-26	-26	-9.65	-0.61	-0.87

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin: 72.6%
Operating margin: -3005.0%
Net margin: -3018.3%
Return on equity, FY2025: -488.3%

Financial strength

Current ratio: 5.56
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 446.0%

Valuation

P/E ratio: –
Price to sales: 35.56
Price to book: 0.94
Dividend yield: –